No Detail Found!

Pharmacoepidemiological evaluation of off label and unlicensed prescription in pediatric intensive care units at tertiary care hospitals of Peshawar, Pakistan

Author(s)
Muhammad Aamir Department of Pharmacy Practice, Faculty of Pharmacy, the University of Lahore, Lahore Pakistan
Muhammad Abid Shah Khyber Medical College Peshawar Pakistan.
Tabassum Naheed Kauser Government Maternity Hospital, Hashtnagri, Peshawar Pakistan
Nouman Khan Kabir Medical College, Gandhara University, Peshawar, Pakistan
Irum Mehmood Khyber Medical College Peshawar Pakistan.
Jamshaid Ali Khan Department of Pharmacy, University of Peshawar Pakistan.
Waheed Iqbal Khyber Medical College Peshawar Pakistan.
Abstract
Population of pediatric intensive care units are at high risk of receiving off label and unlicensed drug use. Little is known about the characteristics and prevalence of unlicensed and off label prescriptions in pediatric intensive care units (PICUs) at tertiary care settings of Pakistan. Case notes of 420 children were reviewed for unlicensed and off label prescriptions during the one year. Medication profiles were assessed using Micromedex. Logistic regression was applied to calculate the odds-ratios for predictors of unlicensed and off label prescriptions. of the total prescriptions, 29.8% prescriptions were unlicensed from FDA and 42.27% prescriptions were off labelled. Dose (32.79%) was the most common reason for off label prescriptions followed by the indication (26.13%) and indication-dose (13.98%). Multivariate regression analysis revealed no significant association between the unlicensed prescriptions with their predictors. In reference to corresponding category, prescribed medications less than 5 (OR 0.280, 95%CL 0.137-0.570) were significantly less likely to receive off label prescriptions as compared to patients received 6 or more medications. Substantial numbers of children are exposed to unlicensed and off label prescriptions. Standards of drug quality, safety and efficacy should apply equally in adults and in pediatrics under ethical perspective. Suitable clinical interventions must be established by drug manufactures and government agencies for improved pediatric pharmacotherapy.
Publication Details
Page(s) 81-87
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
Off label prescribing, unlicensed prescription, pediatric intensive care units, pharmacoepidemiology
0

Citations

0

Downloads

60

Views